Evidence map›Paper›PMID 35204710›Full record

ReviewBiomolecules2022

Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases.

Ana Pérez-García, Marta Torrecilla-Parra, Mario Fernández-de Frutos, Yolanda Martín-Martín, Virginia Pardo-Marqués, Cristina M Ramírez

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. A λ-Dynamics Investigation of InsulinJournal of chemical information and modeling · 2024
    Article
  16. Article
  17. Gut microbiota in insulin resistance: a bibliometric analysis.Journal of diabetes and metabolic disorders · 2024
    Review
  18. A λ-dynamics investigation of insulinbioRxiv : the preprint server for biology · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ana Pérez-GarcíaIMDEA Research Institute of Food and Health Sciences, 28049 Madrid, Spain.
Marta Torrecilla-ParraIMDEA Research Institute of Food and Health Sciences, 28049 Madrid, Spain.
Mario Fernández-de FrutosIMDEA Research Institute of Food and Health Sciences, 28049 Madrid, Spain.
Yolanda Martín-MartínIMDEA Research Institute of Food and Health Sciences, 28049 Madrid, Spain.
Virginia Pardo-MarquésIMDEA Research Institute of Food and Health Sciences, 28049 Madrid, Spain.ORCID 0000-0001-9787-8722
Cristina M RamírezIMDEA Research Institute of Food and Health Sciences, 28049 Madrid, Spain.ORCID 0000-0003-2589-0786
IMDEA Food · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin resistance defines an impairment in the biologic response to insulin action in target tissues, primarily the liver, muscle, adipose tissue, and brain. Insulin resistance affects physiology in many ways, causing hyperglycemia, hypertension, dyslipidemia, visceral adiposity, hyperinsulinemia, elevated inflammatory markers, and endothelial dysfunction, and its persistence leads to the development metabolic disease, including diabetes, obesity, cardiovascular disease, or nonalcoholic fatty liver disease (NAFLD), as well as neurological disorders such as Alzheimer's disease. In addition to classical transcriptional factors, posttranscriptional control of gene expression exerted by microRNAs and RNA-binding proteins constitutes a new level of regulation with important implications in metabolic homeostasis. In this review, we describe miRNAs and RBPs that control key genes involved in the insulin signaling pathway and related regulatory networks, and their impact on human metabolic diseases at the molecular level, as well as their potential use for diagnosis and future therapeutics.

Indexed as

Insulin ResistanceMetabolic DiseasesNon-alcoholic Fatty Liver DiseaseGene Expression RegulationHumansInsulinInsulininsulin resistancemiRNAsposttranscriptional regulationRBPs

Identifiers

PMID35204710
PMCPMC8961590
OpenAlexW4214518368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.